Krebs Biochemicals & Industries Limited engages in the manufacture of active pharmaceutical ingredients in India. It offers androstenedione for steroid intermediate indications, as well as lovastatin and simvastatin for anti-cholesterol applications. The company also develops amlodipine and telmisartan for anti-hypertension; cetirizine for antihistamine; orlistat for anti-obesity; serratiopeptidase for anti-inflammatory; and phenylephrine for cold and cough. In addition, it provides contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.
Research context
Krebs Biochemicals & Industries Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Krebs Biochemicals & Industries Limited is currently in a long term uptrend where the price is trading 4.5% above its 200 day moving average.
From a valuation standpoint, the stock is 8.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 5.2.
Krebs Biochemicals & Industries Limited's total revenue sank by 14.4% to $65M since the same quarter in the previous year.
Its net income has dropped by 13.4% to $-83M since the same quarter in the previous year.
Finally, its free cash flow grew by 0.5% to $-120M since the same quarter in the previous year.
Based on the above factors, Krebs Biochemicals & Industries Limited gets an overall score of 2/5.